tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Advertisement

CanSino Biologics, Inc. Class H (6185) Similar Stocks

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
CanSino Biologics, Inc. Class H
HK$44.94
HK$13.55B
41.78%
2 Buy
0 Hold
0 Sell
Moderate Buy
Guangzhou Baiyunshan Pharmaceutical Holdings Company
HK$19.38
$44.96B
9.63
8.79%
1 Buy
0 Hold
1 Sell
Hold
Livzon Pharmaceutical Group
HK$32.06
$33.45B
12.13
25.11%
1 Buy
1 Hold
1 Sell
Hold
Shanghai Fosun Pharmaceutical (Group) Co
HK$22.42
$77.88B
17.22
47.48%
2 Buy
2 Hold
1 Sell
Hold
China Resources Pharmaceutical Group Ltd.
HK$4.75
HK$31.10B
10.23
-9.94%
Hansoh Pharmaceutical Group Company Limited
HK$36.82
HK$216.05B
41.10
114.44%
16 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6185
CanSino Biologics, Inc. Class H
43.88
8.23
23.09%
HK:0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
19.38
1.45
8.10%
HK:1513
Livzon Pharmaceutical Group
32.06
6.24
24.17%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
22.42
7.39
49.21%
HK:3320
China Resources Pharmaceutical Group Ltd.
4.89
-0.58
-10.59%
HK:3692
Hansoh Pharmaceutical Group Company Limited
36.82
19.85
116.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis